These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35942877)

  • 41. Prevalence and prognostic association of ventricular arrhythmia in non-ischaemic heart failure patients: results from the DANISH trial.
    Boas R; Thune JJ; Pehrson S; Køber L; Nielsen JC; Videbæk L; Haarbo J; Korup E; Bruun NE; Brandes A; Eiskjær H; Thøgersen AM; Philbert BT; Svendsen JH; Dixen U
    Europace; 2021 Apr; 23(4):587-595. PubMed ID: 33257933
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
    Stavrakis S; Asad Z; Reynolds D
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prophylactic implantable cardioverter defibrillators for primary prevention: From implantation to heart transplantation.
    Algalarrondo V; Perault R; Bories MC; Narayanan K; Garcia R; Combes N; Perier MC; Defaye P; Sadoul N; Gras D; Klug D; Bordachar P; Fauchier L; Deharo JC; Leclercq C; Boveda S; Marijon E; Babuty D;
    Arch Cardiovasc Dis; 2018 Dec; 111(12):758-765. PubMed ID: 30078651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease.
    Bansal N; Szpiro A; Reynolds K; Smith DH; Magid DJ; Gurwitz JH; Masoudi F; Greenlee RT; Tabada GH; Sung SH; Dighe A; Go AS
    JAMA Intern Med; 2018 Mar; 178(3):390-398. PubMed ID: 29404570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The gender-paradox among patients with implantable cardioverter-defibrillators: a propensity-matched study.
    Bhavnani SP; Pavuluri V; Coleman CI; Guertin D; Yarlagadda RK; Clyne CA; Kluger J
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):878-84. PubMed ID: 23614760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials.
    Pun PH; Al-Khatib SM; Han JY; Edwards R; Bardy GH; Bigger JT; Buxton AE; Moss AJ; Lee KL; Steinman R; Dorian P; Hallstrom A; Cappato R; Kadish AH; Kudenchuk PJ; Mark DB; Hess PL; Inoue LY; Sanders GD
    Am J Kidney Dis; 2014 Jul; 64(1):32-9. PubMed ID: 24518128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death.
    Bilchick KC; Stukenborg GJ; Kamath S; Cheng A
    J Am Coll Cardiol; 2012 Oct; 60(17):1647-55. PubMed ID: 23021331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can we rely on Danish? Real-world data on patients with nonischemic cardiomyopathy from the German Device Registry.
    Frommeyer G; Andresen D; Ince H; Maier S; Stellbrink C; Kleemann T; Seidl K; Hoffmann E; Zrenner B; Hochadel M; Senges J; Eckardt L
    Heart Vessels; 2019 Jul; 34(7):1196-1202. PubMed ID: 30607538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implantable Cardioverter-Defibrillators in Trials of Drug Therapy for Heart Failure: A Systematic Review and Meta-Analysis.
    Gama F; Ferreira J; Carmo J; Costa FM; Carvalho S; Carmo P; Cavaco D; Morgado FB; Adragão P; Mendes M
    J Am Heart Assoc; 2020 Apr; 9(8):e015177. PubMed ID: 32290732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Right Ventricular Free Wall Strain and Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure.
    Elming MB; Jensen DH; Winsløw UC; Risum N; Butt JH; Yafasova A; Haarbo J; Philbert BT; Svendsen JH; Pehrson S; Køber L; Thune JJ
    J Card Fail; 2023 Jun; 29(6):883-892. PubMed ID: 36708755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thirteen-year nationwide trends in use of implantable cardioverter-defibrillators and subsequent long-term survival.
    Schmidt M; Pedersen SB; Farkas DK; Hjortshøj SP; Bøtker HE; Nielsen JC; Sørensen HT
    Heart Rhythm; 2015 Sep; 12(9):2018-27. PubMed ID: 25937527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description.
    Cheng A; Dalal D; Butcher B; Norgard S; Zhang Y; Dickfeld T; Eldadah ZA; Ellenbogen KA; Guallar E; Tomaselli GF
    J Am Heart Assoc; 2013 Feb; 2(1):e000083. PubMed ID: 23525420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network.
    Greenlee RT; Go AS; Peterson PN; Cassidy-Bushrow AE; Gaber C; Garcia-Montilla R; Glenn KA; Gupta N; Gurwitz JH; Hammill SC; Hayes JJ; Kadish A; Magid DJ; McManus DD; Multerer D; Powers JD; Reifler LM; Reynolds K; Schuger C; Sharma PP; Smith DH; Suits M; Sung SH; Varosy PD; Vidaillet HJ; Masoudi FA
    J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29581222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial.
    Gold MR; Lambiase PD; El-Chami MF; Knops RE; Aasbo JD; Bongiorni MG; Russo AM; Deharo JC; Burke MC; Dinerman J; Barr CS; Shaik N; Carter N; Stoltz T; Stein KM; Brisben AJ; Boersma LVA;
    Circulation; 2021 Jan; 143(1):7-17. PubMed ID: 33073614
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An implantable cardioverter-defibrillator for primary prevention in non-ischemic cardiomyopathy: A systematic review and meta-analysis.
    Wasiak M; Tajstra M; Kosior D; Gąsior M
    Cardiol J; 2023; 30(1):117-124. PubMed ID: 33843044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Automated electrocardiographic quantification of myocardial scar in patients undergoing primary prevention implantable cardioverter-defibrillator implantation: Association with mortality and subsequent appropriate and inappropriate therapies.
    Reichlin T; Asatryan B; Vos MA; Willems R; Huikuri HV; Junttila MJ; Schlögl SC; Hnatkova K; Schaer BA; Malik M; Zabel M; Sticherling C;
    Heart Rhythm; 2020 Oct; 17(10):1664-1671. PubMed ID: 32428669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kidney dysfunction and deterioration of ejection fraction pose independent risk factors for mortality in implantable cardioverter-defibrillator recipients for primary prevention.
    Kreuz J; Horlbeck F; Schrickel J; Linhart M; Fimmers R; Mellert F; Nickenig G; Schwab JO
    Clin Cardiol; 2012 Sep; 35(9):575-9. PubMed ID: 22707222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials.
    Steinberg BA; Al-Khatib SM; Edwards R; Han J; Bardy GH; Bigger JT; Buxton AE; Moss AJ; Lee KL; Steinman R; Dorian P; Hallstrom A; Cappato R; Kadish AH; Kudenchuk PJ; Mark DB; Inoue LY; Sanders GD
    JACC Heart Fail; 2014 Dec; 2(6):623-9. PubMed ID: 25306452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.